• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Castle DecisionDx Improves Melanoma Risk Prediction Data

    PR NEWSWIRE

    DecisionDx-Melanoma Study Shows 2.6% Nodal Positivity Rate

    GLOBENEWSWIRE

    Castle Biosciences` Decisiondx-Um And PRAME Combo Outperforms

    GLOBENEWSWIRE

    Systematic Review and Meta-Analysis Confirms TissueCyphe

    GLOBENEWSWIRE

    Melanoma Panel Recommends Castle Biosciences` DecisionDx-Melanoma

    GLOBENEWSWIRE

    Castle Biosciences Introduces Advancead-Tx

    GLOBENEWSWIRE

    DecisionDx-Melanoma Stratifies Risk Across 13,560 Patients

    GLOBENEWSWIRE

    Castle Biosciences Reports Second Quarter 2025 Results

    GLOBENEWSWIRE

    Castle Biosciences to Speak at Canaccord Genuity Conference

    GLOBENEWSWIRE

    Castle Biosciences CEO Derek Maetzold to Join Panel at 2025 BIO

    GLOBENEWSWIRE

    Castle Bio Highlights Progress on Atopic Dermatitis Gene Test

    BUSINESSWIRE

    Publications Affirm Gene Profile Testing In Melanocytic Lesions

    BUSINESSWIRE

    Integrating Drug-Drug Interactions and Lifestyle Factors with Drug-Gene Interactions Provided by Castle Biosciences’ IDgenetix® Test Significantly Impacted the Number of Drug Recommendations for Patients with Moderate to Severe Depression

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.